Charles Schwab’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.6K | Hold |
23,302
| – | – | ﹤0.01% | 3454 |
|
|
2025
Q1 | $58.3K | Hold |
23,302
| – | – | ﹤0.01% | 3393 |
|
|
2024
Q4 | $68.7K | Hold |
23,302
| – | – | ﹤0.01% | 3423 |
|
|
2024
Q3 | $70.1K | Hold |
23,302
| – | – | ﹤0.01% | 3393 |
|
|
2024
Q2 | $81.1K | Hold |
23,302
| – | – | ﹤0.01% | 3481 |
|
|
2024
Q1 | $123K | Hold |
23,302
| – | – | ﹤0.01% | 3289 |
|
|
2023
Q4 | $120K | Buy |
+23,302
| New | +$120K | ﹤0.01% | 3332 |
|
|
2023
Q2 | – | Sell |
-16,484
| Closed | -$61.7K | – | 3686 |
|
|
2023
Q1 | $61.7K | Buy |
16,484
+2,219
| +16% | +$8.3K | ﹤0.01% | 3311 |
|
|
2022
Q4 | $44.1K | Hold |
14,265
| – | – | ﹤0.01% | 3382 |
|
|
2022
Q3 | $66K | Sell |
14,265
-3,760
| -21% | -$17.4K | ﹤0.01% | 3270 |
|
|
2022
Q2 | $476K | Sell |
18,025
-415
| -2% | -$11K | ﹤0.01% | 3096 |
|
|
2022
Q1 | $686K | Buy |
18,440
+2,259
| +14% | +$84K | ﹤0.01% | 2995 |
|
|
2021
Q4 | $947K | Buy |
16,181
+11
| +0.1% | +$644 | ﹤0.01% | 2934 |
|
|
2021
Q3 | $1.33M | Buy |
16,170
+358
| +2% | +$29.4K | ﹤0.01% | 2786 |
|
|
2021
Q2 | $1.5M | Buy |
15,812
+14,153
| +853% | +$1.34M | ﹤0.01% | 2804 |
|
|
2021
Q1 | $107K | Buy |
+1,659
| New | +$107K | ﹤0.01% | 3375 |
|